reports
- MarketLine Department
Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance R...
Summary Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Sunesis Pharmaceuticals, Inc (Sunesis or 'the company') develops and commercializes oncology therapeutics for the treatment of hematologic and solid cancers. The company's major ...
- MarketLine Department
Pdl Biopharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & All...
Summary Marketline's Pdl Biopharma, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Pdl Biopharma, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organ...
- MarketLine Department
Celator Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partners...
Summary Marketline's Celator Pharmaceuticals, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Celator Pharmaceuticals, Inc. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive br...
Moody's announces completion of a periodic review of ratings of Celgen...
Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Celgene Corporation. Global Credit Research- 14 Jan 2020. New York, January 14, 2020-- Moody's Investors Service has completed a periodic review of the ratings of Celgene Corporation and other ratings that are associated with the same analytical unit.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.